12:00 AM
 | 
Jun 26, 2000
 |  BC Week In Review  |  Company News  |  Deals

AVI, Depomed deal

AVII and DMI will develop oral formulations of one or more of AVII's Neugene...

Read the full 48 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >